Abrogation of estrogen-mediated cellular and biochemical effects by indole-3-carbinol

Nutrition and Cancer

Volumn 41, Issue 1-2, 2001, Pages 180-187

  Ashok, Badithe T ^a   Chen, Yuangen ^a   Liu, Xinyan ^a   Bradlow, H Leon ^b   Mittelman, Abraham ^a   Tiwari, Raj K ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 INDOLEMETHANOL; ANTIESTROGEN; CYTOCHROME P450 1A1; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; ESTRONE; INDOLE DERIVATIVE; INDOLE-3-CARBINOL;

ARTICLE; BRASSICACEAE; BREAST TUMOR; CELL CULTURE; CELL DIVISION; CHEMISTRY; DRUG EFFECT; HUMAN; HYDROXYLATION; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; SIGNAL TRANSDUCTION; VEGETABLE; ANTINEOPLASTIC ACTIVITY; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER PREVENTION; CELL ISOLATION; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; ENZYME INDUCTION; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

BRASSICACEAE; BREAST NEOPLASMS; CELL DIVISION; CYTOCHROME P-450 CYP1A1; ESTRADIOL; ESTROGEN ANTAGONISTS; ESTROGENS; ESTRONE; HUMANS; HYDROXYLATION; INDOLES; PHOSPHORYLATION; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; VEGETABLES; HUMAN; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.;

EID: 0035527492     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635581.2001.9680630     Document Type: Article

References (60)

1. Cancer chemoprevention: Progress and promise
2. Progress in cancer chemoprevention
3. The strategic use of antiestrogen to control the development and growth of breast cancer
4. Molecular mechanisms of antiestrogen action in breast cancer
5. Targeted antiestrogens to prevent breast cancer
6. Progress in understanding breast cancer: Epidemiological and biological interactions
7. Estrogenic regulation of growth and polypeptide growth factor secretion in human breast cancer
8. Antiestrogens: Mechanisms and action in target cells
9. Tamoxifen for prevention of breast cancer. Report of the National Surgical Adjuvant Breast and Bowel Project P-I-study
10. Tamoxifen versus the newer SERMs: What is the evidence?
11. Breast cancer chemoprevention
12. Tripartite steroid hormone receptor pharmacology: Interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones
13. Selective responsiveness of human breast cancer cells to indole-3-carbinol, a chemopreventive agent
14. The chemistry and pharmacology of indole-3-carbinol and 3-methoxymethyl indole
15. Multifunctional aspects of the action of indole-3-carbinol as an anti-tumor agent
16. Screening of potential chemopreventive agents using biochemical markers of carcinogenesis
17. Modulation of drug-metabolizing enzyme expression by condensation products of indole-3-carbinol, an inducer in cruciferous vegetables
18. Effects of indole-3-carbinol on lung tumorigenesis and DNA methylation induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and on the metabolism and disposition of NNK in A/J mice
19. 1 activation
20. 1 metabolism
21. Inhibition of DNA adduct formation of 2-amino-1-methyl-6-phenylimidazole[4,5-b] pyridine and 2-amino-3-methyl-imidazole[4,5-f]quinoline by dietary indole-3-carbinol in female rats
22. Induction of apoptosis in MCF-7 cells is independent of p53 and bax
23. 1 cell cycle arrest of human breast cancer cells
24. Phytoantiestrogens: Cellular and molecular effects in breast cancer
25. Cytostatic and antiestrogenic effects of 2-(indol-3-ylmethyl)-3,3′-diindolylmethane, a major in vivo product of dietary indole-3-carbinol
26. Cloning, chromosomal localization and functional analysis of the murine estrogen receptor β
27. ERβ: Identification and characterization of a novel human estrogen receptor
28. ERβ: A novel estrogen receptor offers the potential for new drug development
29. Estrogen receptor interaction with estrogen response elements
30. Selective estrogen receptor modulation: A personal perspective
31. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen
32. Allosteric silencing of activating function in the 4-hydroxytamoxifen estrogen receptor complex is induced by substituting glycine for aspartate at amino acid 351
33. Analysis of estrogen receptor transcriptional enhancement by a nuclear hormone receptor coactivator
34. Estrogen receptor transcription and transactivation: Estrogen receptor-α and estrogen receptor-β: Regulation by selective estrogen receptor modulators and importance in breast cancer
35. Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation
36. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase
37. Estrogen receptor (ER) α and ERβ exhibit unique pharmacologic properties when coupled to activation of the mitogen-activated protein kinase pathway
38. sk1 regulates estrogen receptor-mediated transcription through phosphorylation of Ser-167
39. Aromatic hydroxylation of estrogens
40. Effects of pesticides on the ratio of 16α/2-hydroxyestrone: A biologic marker of breast cancer risk
41. Endocrine characteristics of human breast epithelial cells, MCF-10F
42. ω-3 fatty acids: Modulation of estrogen metabolism and potential for breast cancer prevention
43. Induction by estrogen metabolite 16α-hydroxyestrone of genotoxic damage and aberrant cell proliferation in mouse mammary epithelial cells in culture
44. Is 2-methoxyestradiol an endogenous estrogen metabolite that inhibits mammary carcinogenesis?
45. Is estradiol a genotoxic mutagenic carcinogen?
46. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
47. Purification and characterization of liver microsomal cytochromes P-450: Electrophoretic, spectral, catalytical and immunochemical properties and inducibility of eight isozymes isolated from rats treated with phenobarbital or β-naphthoflavone
48. Estrogens as a cause of human cancer: The Richard and Hinda Rosenthal Foundation Award Lecture
49. The role of estrogens and progestins in the epidemiology and prevention of breast cancer
50. Long-term responses of women to indole-3-carbinol or a high-fiber diet
51. Effects of dietary indole-3-carbinol on estradiol metabolism and spontaneous mammary tumors in mice
52. 1 in the rat
53. Organ-selective induction of cytochrome P-450-dependent activities by indole-3-carbinol-derived products: Influence on covalent binding of benzo[a]pyrene to hepatic and pulmonary DNA in the rat
54. Inhibition of polycyclic aromatic hydrocarbon-induced neoplasia by naturally occurring indoles
55. Molecular biology of the Ah receptor and its role in carcinogenesis
56. Aryl hydrocarbon receptor-mediated antiestrogenic and antitumorigenic activity of diindolylmethane
57. Indole-3-carbinol is a negative regulator of estrogen receptor-α signaling in human tumor cells
58. Ligand-independent activation of estrogen receptor function by 3,3′-diindolyl-methane in human breast cancer cells
59. The major cyclic trimer product of indole-3-carbinol is a strong agonist of the estrogen receptor signaling pathway